Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 May;62(5):1848–1853. doi: 10.1128/iai.62.5.1848-1853.1994

Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

W S Pomat 1, D Lehmann 1, R C Sanders 1, D J Lewis 1, J Wilson 1, S Rogers 1, T Dyke 1, M P Alpers 1
PMCID: PMC186424  PMID: 8168948

Abstract

The immunoglobulin G (IgG) antibody responses to a pneumococcal polysaccharide vaccine were examined for 480 children aged 3 months to 5 years and living in Tari, Southern Highlands Province, Papua New Guinea. Antipneumococcal IgG to the seven serotypes most frequently causing invasive disease (types 2, 5, 6B, 7F, 14, 19F, and 23F) was measured by an enzyme-linked immunosorbent assay in serum collected before vaccination and 1 and 6 months after vaccination. Prevaccination antibody levels fell rapidly after 3 months of age and remained low throughout the first 2 years of life. One month after vaccination, geometric mean titers of antipneumococcal IgG to serotypes 2, 7F, 23F, and 5 were at least twice those of antibodies in nonvaccinated children of the same age from the ages of 5, 6, 9, and 12 months onwards, respectively; postvaccination antibody responses to serotypes 6B, 14, and 19F rose gradually during the second year of life. Elevated antibody titers to serotypes 2 and 7F were maintained 6 months after vaccination. Thus, young Papua New Guinean children are capable of mounting a good immune response to some pneumococcal capsular polysaccharides from a young age, and the antibody responses to capsular polysaccharides are consistent with studies in developed countries. However, in Papua New Guinea, the serogroup distribution of invasive disease matches the immunogenic components of the pneumococcal polysaccharide vaccine more closely than in developed countries, a fact which helps to explain the results of controlled trials in Papua New Guinea, in which this vaccine prevented death and severe morbidity from pneumonia in young children.

Full text

PDF
1848

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker J., Gratten M., Riley I., Lehmann D., Montgomery J., Kajoi M., Gratten H., Smith D., Marshall T. F., Alpers M. P. Pneumonia in children in the Eastern Highlands of Papua New Guinea: a bacteriologic study of patients selected by standard clinical criteria. J Infect Dis. 1989 Feb;159(2):348–352. doi: 10.1093/infdis/159.2.348. [DOI] [PubMed] [Google Scholar]
  2. Borgoño J. M., McLean A. A., Vella P. P., Woodhour A. F., Canepa I., Davidson W. L., Hilleman M. R. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc Soc Exp Biol Med. 1978 Jan;157(1):148–154. doi: 10.3181/00379727-157-40010. [DOI] [PubMed] [Google Scholar]
  3. Douglas R. M., Paton J. C., Duncan S. J., Hansman D. J. Antibody response to pneumococcal vaccination in children younger than five years of age. J Infect Dis. 1983 Jul;148(1):131–137. doi: 10.1093/infdis/148.1.131. [DOI] [PubMed] [Google Scholar]
  4. Eskola J., Takala A. K., Kela E., Pekkanen E., Kalliokoski R., Leinonen M. Epidemiology of invasive pneumococcal infections in children in Finland. JAMA. 1992 Dec 16;268(23):3323–3327. [PubMed] [Google Scholar]
  5. Goldblatt D., Levinsky R. J., Turner M. W. Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood. J Infect Dis. 1992 Sep;166(3):632–634. doi: 10.1093/infdis/166.3.632. [DOI] [PubMed] [Google Scholar]
  6. Gratten M., Barker J., Shann F., Gerega G., Montgomery J., Kajoi M., Lupiwa T. The aetiology of purulent meningitis in highland children: a bacteriological study. P N G Med J. 1985 Dec;28(4):233–240. [PubMed] [Google Scholar]
  7. Gratten M., Montgomery J. The bacteriology of acute pneumonia and meningitis in children in Papua New Guinea: assumptions, facts and technical strategies. P N G Med J. 1991 Sep;34(3):185–198. [PubMed] [Google Scholar]
  8. Klein J. O. The epidemiology of pneumococcal disease in infants and children. Rev Infect Dis. 1981 Mar-Apr;3(2):246–253. doi: 10.1093/clinids/3.2.246. [DOI] [PubMed] [Google Scholar]
  9. Koskela M. Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr Infect Dis J. 1987 Jun;6(6):519–526. doi: 10.1097/00006454-198706000-00006. [DOI] [PubMed] [Google Scholar]
  10. Lehmann D. Epidemiology of acute respiratory tract infections, especially those due to Haemophilus influenzae, in Papua New Guinean children. J Infect Dis. 1992 Jun;165 (Suppl 1):S20–S25. doi: 10.1093/infdis/165-supplement_1-s20. [DOI] [PubMed] [Google Scholar]
  11. Lehmann D., Marshall T. F., Riley I. D., Alpers M. P. Effect of pneumococcal vaccine on morbidity from acute lower respiratory tract infections in Papua New Guinean children. Ann Trop Paediatr. 1991;11(3):247–257. doi: 10.1080/02724936.1991.11747510. [DOI] [PubMed] [Google Scholar]
  12. Lehmann D. Mortality and morbidity from acute lower respiratory tract infections in Tari, Southern Highlands Province 1977-1983. P N G Med J. 1991 Sep;34(3):174–184. [PubMed] [Google Scholar]
  13. Leinonen M., Säkkinen A., Kalliokoski R., Luotonen J., Timonen M., Mäkelä P. H. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis. 1986 Jan-Feb;5(1):39–44. doi: 10.1097/00006454-198601000-00008. [DOI] [PubMed] [Google Scholar]
  14. Mastro T. D., Ghafoor A., Nomani N. K., Ishaq Z., Anwar F., Granoff D. M., Spika J. S., Thornsberry C., Facklam R. R. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet. 1991 Jan 19;337(8734):156–159. doi: 10.1016/0140-6736(91)90813-5. [DOI] [PubMed] [Google Scholar]
  15. Musher D. M., Luchi M. J., Watson D. A., Hamilton R., Baughn R. E. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis. 1990 Apr;161(4):728–735. doi: 10.1093/infdis/161.4.728. [DOI] [PubMed] [Google Scholar]
  16. Mäkelä P. H., Karma P., Sipilä M., Pukander J., Leinonen M. Possibilities of preventing otitis media by vaccination. Scand J Infect Dis Suppl. 1983;39:34–38. [PubMed] [Google Scholar]
  17. Orange M., Gray B. M. Pneumococcal serotypes causing disease in children in Alabama. Pediatr Infect Dis J. 1993 Mar;12(3):244–246. doi: 10.1097/00006454-199303000-00015. [DOI] [PubMed] [Google Scholar]
  18. Pedersen F. K., Henrichsen J. Detection of antibodies to pneumococcal capsular polysaccharides by enzyme-linked immunosorbent assay. J Clin Microbiol. 1982 Mar;15(3):372–378. doi: 10.1128/jcm.15.3.372-378.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Riley I. D., Everingham F. A., Smith D. E., Douglas R. M. Immunisation with a polyvalent pneumococcal vaccine. Effect of respiratory mortality in children living in the New Guinea highlands. Arch Dis Child. 1981 May;56(5):354–357. doi: 10.1136/adc.56.5.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Riley I. D., Lehmann D., Alpers M. P., Marshall T. F., Gratten H., Smith D. Pneumococcal vaccine prevents death from acute lower-respiratory-tract infections in Papua New Guinean children. Lancet. 1986 Oct 18;2(8512):877–881. doi: 10.1016/s0140-6736(86)90409-5. [DOI] [PubMed] [Google Scholar]
  21. Riley I. D., Lehmann D., Alpers M. P. Pneumococcal vaccine trials in Papua New Guinea: relationships between epidemiology of pneumococcal infection and efficacy of vaccine. Rev Infect Dis. 1991 May-Jun;13 (Suppl 6):S535–S541. doi: 10.1093/clinids/13.supplement_6.s535. [DOI] [PubMed] [Google Scholar]
  22. Sell S. H., Wright P. F., Vaughn W. K., Thompson J., Schiffman G. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev Infect Dis. 1981 Mar-Apr;3 (Suppl):S97–107. doi: 10.1093/clinids/3.supplement_1.s97. [DOI] [PubMed] [Google Scholar]
  23. Shann F., Gratten M., Germer S., Linnemann V., Hazlett D., Payne R. Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea. Lancet. 1984 Sep 8;2(8402):537–541. doi: 10.1016/s0140-6736(84)90764-5. [DOI] [PubMed] [Google Scholar]
  24. Sloyer J. L., Jr, Ploussard J. H., Karr L. J., Schiffman G. D. Immunologic response to pneumococcal polysaccharide vaccine in infants. Ann Otol Rhinol Laryngol Suppl. 1980 May-Jun;89(3 Pt 2):351–356. doi: 10.1177/00034894800890s382. [DOI] [PubMed] [Google Scholar]
  25. Temple K., Greenwood B., Inskip H., Hall A., Koskela M., Leinonen M. Antibody response to pneumococcal capsular polysaccharide vaccine in African children. Pediatr Infect Dis J. 1991 May;10(5):386–390. doi: 10.1097/00006454-199105000-00008. [DOI] [PubMed] [Google Scholar]
  26. Wall R. A., Corrah P. T., Mabey D. C., Greenwood B. M. The etiology of lobar pneumonia in the Gambia. Bull World Health Organ. 1986;64(4):553–558. [PMC free article] [PubMed] [Google Scholar]
  27. Witt C. S., Pomat W., Alpers M. P. Pneumococcal antibody concentrations in young Papua New Guinean Highland children with pneumonia. Pediatr Infect Dis J. 1989 Aug;8(8):533–534. doi: 10.1097/00006454-198908000-00013. [DOI] [PubMed] [Google Scholar]
  28. Witt C. S., Pomat W., Lehmann D., Alpers M. P. Antibodies to pneumococcal polysaccharides in pneumonia and response to pneumococcal vaccination in young children in Papua New Guinea. Clin Exp Immunol. 1991 Feb;83(2):219–224. doi: 10.1111/j.1365-2249.1991.tb05618.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES